Cold Plasma Decontamination for Food & Packaging Market Size & Share 2026-2035

Cold Plasma Decontamination for Food & Packaging Market Size

The cold plasma decontamination for food and packaging market was valued at USD 290 million in 2025 and is projected to increase from USD 330 million in 2026 to USD 1 billion by 2035, representing approximately 13.7% CAGR over 2026 to 2035.

Cold plasma uses a partially ionized gas at low bulk temperature to generate reactive oxygen and nitrogen species, charged particles, and UV radiation. Those species can disrupt microbial membranes and genetic material while avoiding the thermal load associated with conventional pasteurization methods ^{[1]Royal Society of Chemistry - A comprehensive review on cold plasma applications in the food industry, 2025 - pubs.rsc.org}. This makes the technology relevant where processors must protect texture, color, flavor, or functional properties while reducing pathogens on fresh produce, ready-to-eat foods, protein products, and food-contact packaging.

The addressable need is substantial. The World Health Organization estimates that foodborne hazards caused approximately 866 million illnesses, 1.52 million deaths, and 57.1 million disability-adjusted life years globally in 2021, alongside USD 310 billion in productivity losses ^{[2]World Health Organization - Estimating the burden of foodborne diseases, 2025 - who.int}. Cold plasma is not a universal replacement for chemical or thermal controls, but it offers an additional intervention where rinse chemistry, heat exposure, residue management, or recontamination after packaging create operational constraints.

Evidence is increasingly moving beyond single-organism laboratory tests. A systematic review of packaging studies reported a mean pathogen reduction of 4.11 ± 1.75 log₁₀ across bacteria and fungi, while in-package configurations can apply treatment after sealing and thereby reduce exposure to post-treatment contamination. Commercial adoption remains uneven because treatment efficacy depends on source design, voltage, gas composition, product geometry, moisture, line speed, and validation requirements.

The supplier base combines established web-treatment and surface-engineering companies with plasma specialists. Plasmatreat GmbH and Nordson Corporation together account for approximately 31% of 2025 market revenue. Their position reflects the importance of integrating plasma equipment into packaging converting and food-processing lines rather than supplying a standalone laboratory device.

Adoption will therefore depend less on whether plasma can inactivate microorganisms under controlled conditions and more on whether suppliers can deliver repeatable dose control at commercial throughput. Equipment providers that pair modular hardware with application data, traceable process monitoring, and regulatory-ready validation packages are positioned to convert technical performance into procurement acceptance. The projected growth rate reflects an expanding use case, but also a market whose pace remains governed by approval pathways and integration economics.

Key Drivers

Rising demand for non-thermal preservation

Thermal interventions can impair heat-sensitive vitamins, pigments, flavor compounds, and protein structures. Cold plasma offers a non-thermal alternative because its antimicrobial effect is driven by reactive species rather than bulk heating. Studies cited in food-processing reviews have reported pathogen reductions on leafy greens, eggshells, dairy matrices, and animal proteins, while preserving quality attributes under treatment conditions optimized for the specific matrix ^{[3]Foods - Recent advances and potential applications of atmospheric pressure cold plasma technology for sustainable food processing, 2022 - mdpi.com}.

The strongest commercial rationale appears in products where quality loss has a direct price consequence. Fresh-cut produce, chilled seafood, ready-to-eat proteins, and premium dairy products are vulnerable to contamination yet cannot absorb substantial thermal treatment without changing product positioning. In these categories, an in-line treatment step can be assessed against avoided spoilage, reduced recalls, and lower dependence on chemical sanitizers.

Food-safety controls and shelf-life economics

The documented burden of foodborne illness raises the commercial cost of process failure for processors, retailers, and food-service suppliers. Cold plasma can be applied to products, contact surfaces, or packaging materials, giving operators more than one point of intervention. Its relevance increases where cleaning systems must control biofilms, prevent post-packaging contamination, or maintain hygiene without increasing chemical handling requirements.

Plasma-activated water is particularly important because it separates plasma generation from application. A 2024 clean-in-place study found that plasma-activated water achieved a 4.2 log CFU/coupon reduction on mixed-species biofilm associated with whey-protein fouling, compared with 1.8 log CFU/coupon for the conventional sanitizer evaluated under the same study conditions ^{[4]Journal of Food Science - Assessing plasma-activated water as an acidic and sanitizer solution in clean-in-place and comparing efficacy with other traditional CIP chemicals, 2024 - doi.org}. This creates an adoption pathway for dairy and protein-processing facilities that can use existing liquid-distribution infrastructure rather than redesigning every production line around direct plasma exposure.

Regulatory pressure to reduce chemical inputs

Chemical-reduction policies and tightening scrutiny of food-contact materials are strengthening the case for residue-light decontamination options. The EU Farm to Fork strategy calls for a 50% reduction in the use and risk of chemical pesticides by 2030, while the European Food Safety Authority updated its novel-food application guidance in June 2024. These developments do not constitute a blanket authorization for cold plasma, but they increase the value of safety, compositional, and process-characterization evidence.

For suppliers, the opportunity lies in treating regulatory work as a product-development function. Process windows must show how voltage, gas chemistry, treatment duration, and food composition affect both microbial performance and chemical outcomes. That requirement favors vendors that can support processor trials with industrially relevant monitoring rather than only laboratory demonstrations.

Key Restraints

Capital cost and line-integration requirements

Production-scale cold plasma installations require high-voltage power supplies, safety systems, controls, and mechanical integration with conveyors, filling lines, wash systems, or web-handling equipment. The equipment cost is only part of the investment decision; processors must also validate treatment uniformity at operating speed and demonstrate that treatment does not compromise food quality or packaging performance.

The burden is greatest for smaller processors and facilities with heterogeneous product formats. A treatment head optimized for a flat packaging web cannot simply be repurposed for irregular produce or sealed trays. This limits early adoption to operations where throughput is high, product geometry is repeatable, or contamination and shelf-life risks justify dedicated engineering.

Absence of harmonized food-treatment frameworks

Cold plasma is not governed by a comprehensive, technology-specific food-treatment approval framework across major markets. Regulatory assessment can involve food-safety authorities, agricultural regulators, and food-contact or packaging requirements, depending on the product and the treatment configuration. The result is not merely procedural delay; it also changes the data a processor must generate before committing to commercial-scale equipment.

The technical diversity of plasma systems compounds that issue. DBD, plasma jets, gliding arcs, and plasma-activated media generate different reactive-species profiles. Gas composition, humidity, voltage, and exposure geometry can further alter outcomes. A generalized regulatory claim therefore cannot substitute for validated, application-specific evidence. This uncertainty favors equipment suppliers with standardizable process architectures and slows penetration into commodity food categories.

Capital spending and regulatory uncertainty reinforce each other: a processor is less willing to fund integrated equipment before an approval route is understood, while regulators require industrially relevant evidence that often cannot be generated on benchtop systems. The companies best placed to break this cycle will lower trial costs, standardize operating windows, and build application dossiers around a limited number of high-value food and packaging use cases rather than pursuing undifferentiated market coverage.

Cold Plasma Decontamination for Food & Packaging Market Segment Analysis

By Technology

Dielectric barrier discharge held the largest 2025 share at 36%, equivalent to USD 104.4 million, and is projected to reach USD 348.0 million by 2035 at approximately 12.8% CAGR. Its relevance comes from atmospheric-pressure operation, stable discharge behavior, and electrode configurations that can be adapted to conveyors, tunnels, and packaging webs. DBD is also prominent in packaging research, where it can produce substantial microbial reductions on polymer surfaces without requiring a vacuum chamber ^{[5]Frontiers in Physics - Evaluating atmospheric pressure cold plasma decontamination techniques for packaging materials: a systematic review and meta-analysis, 2024 - frontiersin.org}.

Atmospheric pressure plasma jet accounted for 24% of 2025 revenue, or USD 69.6 million, and is projected to reach USD 276.9 million by 2035 at approximately 14.8% CAGR. Its nozzle-based delivery makes it useful for irregular surfaces and localized treatment zones. The advantage is precision; the trade-off is a greater dependence on gas flow, ambient conditions, and process control.

Corona discharge represented 18% of the market in 2025, or USD 52.2 million, and is projected to reach USD 128.5 million by 2035 at approximately 9.4% CAGR. It remains important in flexible packaging because it raises polymer surface energy and improves adhesion for inks, coatings, and laminates. Its growth is slower because surface activation, rather than direct microbial decontamination, remains its central commercial role ^{[6]Enercon Industries Corporation - Plasma3 atmospheric plasma surface treating - enerconind.com}.

Gliding arc discharge held 9% of 2025 revenue, or USD 26.1 million, and is projected to increase to USD 136.9 million by 2035 at approximately 17.8% CAGR. The technology is particularly relevant to high-volume plasma-activated water production. Its higher reactive-species density and liquid-treatment potential offer a route to fresh-produce washing and sanitation systems that do not require every product to pass through a direct plasma zone.

Radio-frequency plasma accounted for 7% of the market in 2025, or USD 20.3 million, and is projected to reach USD 62.7 million by 2035 at approximately 12.1% CAGR. It is more closely aligned with precision packaging treatment, barrier modification, and controlled surface functionality than with high-throughput bulk food treatment. The Others segment represented 6% of 2025 revenue, or USD 17.4 million, and is projected to reach USD 92.0 million by 2035 at approximately 17.8% CAGR, led by compact and emerging configurations such as piezoelectric direct discharge systems.

By Treatment Mode

Direct plasma treatment held 58% of market revenue in 2025, equivalent to USD 168.2 million, and is projected to reach USD 525.6 million by 2035 at approximately 12.1% CAGR. Direct exposure maximizes contact with short-lived reactive species and fits packaging webs, sealed-package systems, and products moving through controlled treatment zones. Its established position explains its lower growth rate relative to emerging indirect modes.

Indirect/plasma-activated medium treatment represented 35% of 2025 revenue, or USD 101.5 million, and is projected to reach USD 446.2 million by 2035 at approximately 15.9% CAGR. By retaining longer-lived reactive species in water or another carrier, the approach lets processors distribute treatment through existing wash, misting, and clean-in-place systems. Pilot-scale plasma-activated water research on romaine lettuce and steamed rice cakes demonstrated 1.3 to 2.5 log reductions of key foodborne pathogens, illustrating why the approach is commercially attractive for produce and prepared-food operations.

Other treatment modes accounted for 7% of 2025 revenue, or USD 20.3 million, and are expected to reach USD 73.2 million by 2035 at approximately 13.7% CAGR. These include hybrid configurations that combine plasma with modified-atmosphere packaging, UV exposure, or liquid treatment. Their potential lies in extending the useful treatment window, though commercialization depends on proving repeatability across different package formats and product compositions.

By Application

Food applications represented 65% of the market in 2025, totaling USD 188.5 million, and are projected to reach USD 608.2 million by 2035 at approximately 12.4% CAGR. Fresh produce, animal proteins, dairy, dry foods, and ready-to-eat products are the principal targets because they face high contamination risk yet often cannot tolerate intensive heat treatment. Direct plasma and plasma-activated water can both support these applications, but regulatory evidence must remain product-specific.

Packaging applications accounted for 35% of 2025 revenue, or USD 101.5 million, and are forecast to reach USD 436.8 million by 2035 at approximately 15.7% CAGR. The segment has a clearer early commercial case because plasma can combine decontamination with surface activation, printing adhesion, coating performance, and compatibility with recyclable or bio-based substrates. A packaging application can consequently justify investment through both food-safety and converting-line performance metrics.

Indirect treatment is strategically significant because it lowers the operational barrier between laboratory efficacy and plant adoption. Rather than requiring a processor to redesign an entire food line around a plasma zone, plasma-activated media can be integrated into existing fluid systems. Packaging applications compound that advantage: they offer dual value through microbial control and surface functionality, making them a more immediate route to measurable return on investment than many direct food-treatment applications.

Cold Plasma Decontamination for Food & Packaging Market Regional Analysis

North America

North America held 33% of market revenue in 2025, or USD 95.7 million, and is projected to reach USD 286.3 million by 2035 at approximately 11.6% CAGR. The U.S. sub-market was valued at USD 75.9 million in 2025 and is projected to reach USD 227.0 million by 2035. Demand is supported by large food processors and packaging converters evaluating non-thermal controls, although multi-agency oversight and application-specific validation slow broad direct-food deployment.

Europe

Europe accounted for 27% of 2025 revenue, equivalent to USD 78.3 million, and is projected to reach USD 230.5 million by 2035 at approximately 11.4% CAGR. The region combines a strong supplier base with a demanding regulatory environment. Germany is particularly important because it hosts Plasmatreat, Relyon Plasma, and PVA TePla, while European food-contact and chemical-reduction policies raise the value of residue-conscious treatment approaches ^{[7]European Food Safety Authority - Novel food application procedure and EFSA guidance, 2024 - efsa.europa.eu}.

Asia Pacific

Asia Pacific represented 30% of market revenue in 2025, or USD 87.0 million, and is projected to reach USD 426.4 million by 2035 at approximately 17.1% CAGR. The region's growth reflects expanding organized food processing, food-safety modernization, and local plasma-equipment manufacturing capability. South Korean pilot-scale plasma-activated water research illustrates the region's role in moving technology from experimental conditions toward commercially relevant processing volumes ^{[8]Seoul National University - Pilot-scale plasma activated water treatment for decontaminating romaine lettuce and steamed rice cakes, 2024 - snu.elsevierpure.com}.

Latin America

Latin America accounted for 6% of the market in 2025, or USD 17.4 million, and is forecast to reach USD 63.7 million by 2035 at approximately 13.7% CAGR. Brazil and Mexico are the key markets, supported by export-oriented fruit, meat, seafood, and packaged-food industries. Investment is likely to remain concentrated among larger processors that can link treatment upgrades to export certification, shelf-life management, and buyer requirements.

Middle East & Africa

Middle East & Africa represented 4% of 2025 market revenue, totaling USD 11.6 million, and is projected to reach USD 37.6 million by 2035 at approximately 13.0% CAGR. Demand is concentrated in Gulf food-import markets and South African export sectors. The primary constraint is not the relevance of food safety, but the limited availability of validated systems and local process-integration support for smaller food processors.

Europe and North America play a different role. Their equipment suppliers, technical institutions, and regulatory systems make them critical proving grounds for process validation, even when direct food-treatment approvals take longer to establish. Suppliers that validate a repeatable application in these markets can use the resulting evidence to support expansion into export-oriented processors in Latin America, Asia Pacific, and the Middle East & Africa.

Cold Plasma Decontamination for Food & Packaging Market Share & Competitive Landscape

The market is moderately concentrated. Plasmatreat GmbH, Nordson Corporation, Enercon Industries Corporation, Vetaphone A/S, and Relyon Plasma GmbH (TDK) together account for approximately 56% of 2025 revenue. Competition is determined by application-engineering depth, line-integration capability, source technology, and the ability to support customers with data needed for process qualification.

Plasmatreat GmbH, with approximately 18% market share, is a leading supplier of atmospheric-pressure plasma equipment. Its Openair-Plasma technology is widely used for packaging surface activation, and the company expanded its production capacity in 2024 while broadening its product activity into plasma-enhanced residue cleaning and functional coatings ^{[9]Plasmatreat GmbH - Collaboration of Plasmatreat and Fraunhofer IFAM, 2024 - plasmatreat.com}.

Nordson Corporation, with approximately 13% share, competes through its broader packaging-line portfolio, including adhesive dispensing, coating, and surface-treatment capabilities. Enercon Industries Corporation, with approximately 11% share, remains important in corona and atmospheric plasma treatment for film and web converting, particularly where food packaging requires controlled surface-energy performance.

Vetaphone A/S, with approximately 8% share, positions its iPlasma technology for applications where conventional corona treatment does not provide sufficient surface energy. The company states that its iPlasma systems can achieve surface tensions up to 60 dyne/cm on BOPP, supporting water-based and UV-ink adhesion in packaging applications.

Relyon Plasma GmbH, a TDK subsidiary with approximately 6% share, focuses on compact piezoelectric direct discharge and pulsed atmospheric arc systems. Its MediPlas platform targets food decontamination, seed treatment, plasma-activated water generation, and packaging applications, reflecting the market's growing interest in modular sources that can be evaluated without committing to a full production-scale line.

ADTEC Plasma Technology, PVA TePla AG, Europlasma NV, Tantec A/S, Henniker Plasma, AcXys Technologies, PlasmaLeap Technologies, and Neoplas Tools GmbH occupy more specialized positions. Europlasma offers vacuum chambers and roll-to-roll substrate processing capability; AcXys Technologies provides atmospheric plasma equipment and a plasma-as-a-service model; Henniker Plasma serves research and specialized surface-engineering applications; and Neoplas Tools commercializes focused cold plasma jet systems derived from medical plasma technology. Their competitive relevance depends on translating specialist plasma control, coating, or localized-treatment capabilities into validated food and packaging applications.

Recent Industry Developments

Plasmatreat GmbH - HydroPlasma introduction and production expansion

Plasmatreat marked the 30th anniversary of its Openair-Plasma technology in 2025 and introduced HydroPlasma, a plasma-enhanced process intended to remove inorganic residues before downstream activation, coating, or printing. The company had also commissioned a new manufacturing hall at its Steinhagen headquarters in 2024.

Plasmatreat GmbH and Fraunhofer IFAM - PFAS-free coating collaboration

Plasmatreat announced a 2024 technology-transfer collaboration with Fraunhofer IFAM covering PFAS-free PLASLON and UltraPLAS coating technologies. The collaboration is intended to support industrial qualification of plasma-enabled surface treatments for packaging and related applications.